References
- Abaci A, Catli G, Anik A, et al. (2013). The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children. Pediatr Diabetes 14:189–95
- Alkalay AL, Graham JM Jr, Pomerance JJ. (1998). Evaluation of neonates born with intrauterine growth retardation: review and practice guidelines. J Perinatol 18:142–51
- Anwar GM, Yamamah G, Ibrahim A, et al. (2014). Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance. Regul Pept 188:21–4
- Bodnar LM, Ness RB, Markovic N, Roberts JM. (2005). The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 15:475–82
- Bonnet MS, Pecchi E, Trouslard J, et al. (2009). Central nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus. J Neuroinflammation 6:27. doi:10.1186/1742-2094-6-27
- Brown MA, Lindheimer MD, de Swiet M, et al. (2001). The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20:IX–XIV
- Clark SL, Belfort MA, Dildy GA, et al. (2008). Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol 199:36.e1–5; discussion 91–2. e7–11
- Deniz R, Gurates B, Aydin S, et al. (2012). Nesfatin-1 and other hormone alterations in polycystic ovary syndrome. Endocrine 42:694–9
- Lynch AM, Eckel RH, Murphy JR, et al. (2012). Prepregnancy obesity and complement system activation in early pregnancy and the subsequent development of preeclampsia. Am J Obstet Gynecol 206:428.e1–8
- Molvarec A, Szarka A, Walentin S, et al. (2010). Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens Res 33:892–8
- Molvarec A, Szarka A, Walentin S, et al. (2011). Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol 9:124. doi: 10.1186/1477-7827-9-124
- Oh-I S, Shimizu H, Satoh T, et al. (2006). Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443:709–12
- Osaki A, Shimizu H. (2014). Peripheral administration of nesfatin-1 increases blood pressure in mice. Hypertens Res 37:185–6
- Reyes LM, García RG, Ruiz SL, et al. (2012). Risk factors for preeclampsia in women from Colombia: a case-control study. PLoS One 7:e41622
- Szarka A, Rigó J Jr, Lázár L, et al. (2010). Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 11:59
- Tang CH, Fu XJ, Xu XL, et al. (2012). The anti-inflammatory and anti-apoptotic effects of nesfatin-1 in the traumatic rat brain. Peptides 36:39–45
- Tsuchiya T, Shimizu H, Yamada M, et al. (2010). Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) 73:484–90
- Vitoratos N, Hassiakos D, Iavazzo C. (2012). Molecular mechanisms of preeclampsia. J Pregnancy 2012:298343
- Walsh SW. (2007). Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab 18:365–70
- Yamawaki H, Takahashi M, Mukohda M, et al. (2012). A novel adipocytokine, nesfatin-1 modulates peripheral arterial contractility and blood pressure in rats. Biochem Biophys Res Commun 418:676–81
- Zhao Y, Ma X, Wang Q, et al. (2014). Nesfatin-1 correlates with hypertension in overweight or obese Han Chinese population. Clin Exp Hypertens. [Epub ahead of print]
- Zorba E, Vavilis D, Venetis CA, et al. (2012). Visfatin serum levels are increased in women with preeclampsia: a case-control study. J Matern Fetal Neonatal Med 25:1668–73